Advertisement
Screener

MEDICINOVA, INC. (MNOV) Net Margin

MEDICINOVA, INC. (MNOV) Net Margin

  • 2026-06-30: Net Margin -504.79%.
  • 2026-03-31: Net Margin -1383.14%.
  • 2025-12-31: Net Margin -1846.78%.
  • 2025-09-30: Net Margin -2473.56%.

Complete source-backed net margin history.

Available history
2012-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-504.79%
2026-03-31-1383.14%
2025-12-31-1846.78%
2025-09-30-2473.56%
2025-06-30-2437.75%
2023-09-30-72.31%
2021-09-30-9544.45%
2021-03-31-4.69%
2013-03-31-74271.23%
2012-12-31-7159.59%
2012-09-30-2839.07%
2012-06-30-462.16%
2012-03-31-2022.88%

Annual Net Margin

DateNet Margin
2025-12-31-2928.78%
2023-12-31-857.15%
2021-12-31-251.00%
2012-12-31-1365.76%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
Atrium Therapeutics, Inc. (RNA)United States$0.140B